formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab. 2004 Nov; 89(11):5429-34.
Shores MM et al. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006 Aug 14; 166(15):1660-5
Sinha-Hikim I et al. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab. 2006 Aug; 91(8):3024-33.
Somboonporn W., Davis S., Seif M.W. and Bell R. (2005). Testosterone for peri- and postmenopausal women. Cochrane Database of Systematic Reviews, Issue 4.
Stattin P et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer. 2004 Jan 20; 108(3):418-24
Svartberg J. Epidemiology: testosterone and the metabolic syndrome. Int J Impot Res. 2006 Jul 20
Tan RS A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male. 2003 Mar; 6(1):13-7.
Tilakaratne A, Soory M. Effects of the anti-androgen finasteride on 5 alpha-reduction of androgens in the presence of progesterone in human gingival fibroblasts. J Periodontal Res. 2000 Aug; 35(4):179-85
Travison TG et al. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2006 Oct 24
Tsujimura A et al. Treatment with human chorionic gonadotropin for PADAM: a preliminary report. Aging Male. 2005 Sep-Dec; 8(3-4):175-9
Turhan S et al. The association between androgen levels and premature coronary artery disease in men. Coron Artery Dis. 2007 May; 18(3):159-62.
Turna B et al. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res. 2004 Dec 09
van den Beld et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men J Clin Endocrinol Metab 2000 Sep;85(9):3276-82
Vermeulen A. Androgens in the aging male. J Clin Endocrinol Metab. 1991. 73:221–224.
Vigna GB et al. Testosterone replacement, cardiovascular system and risk factors in the aging male. J Endocrinol Invest. 2005; 28(11 Suppl Proceedings):69-74
Webb CM et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999 Oct 19; 100(16):1690-6.
Yeap BB et al Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health In Men Study. Clin Endocrinol (Oxf). 2008 Mar; 68(3):404-12
Yeap BB et al In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. Eur J Endocrinol. 2007 May;156(5):585-94
Yeap BB et al Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 2008 Mar; 65(3):283-9.
Yeap BB et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab. 2009 Jul; 94(7):2353-9.
Yeap BB et al. Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res. 2009 Jan-Feb; 21(1):24-36.
Yeap BB et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men. The Health In Men Study. Eur JEndocrinol. 2009 Aug 18.
Yeap BB et al. Serum testosterone levels correlate with haemoglobin in middle-aged and older men. Intern Med J. 2008 Aug 16.
Yeap BB et al. Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study. Clin Endocrinol (Oxf). 2009 Mar; 70(3):455-63.
Yeap BB et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol. 2008 Jun; 158(6):785-92.
Yeap BB et al. Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. J Alzheimers Dis. 2008 Jun; 14(2):201-8.
Yeap BB et al. Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab. 2009 Feb; 5(2):113-21.
Zitzmann M Hormone substitution in male hypogonadism Mol Cell Endocrinol 2000 Mar 30; 161(1-2):73-88
REFERENCES
1.Zs.-Nagy I. “Is consensus in anti-aging medical intervention an elusive expectation or a realistic goal?” Archives of Gerontology and Geriatrics, Volume 48 Issue 3; May-June 2009, 271-276.
2.Interview with Tanjung Subrata, MD, 16 September 2013.
3.Interview with Tim Bolen, 30 July 2013.
4.Perls TT, Reisman NR, Olshansky SJ. "Provision or Distribution of Growth Hormone for 'Anti-Aging': Clinical and Legal Issues." JAMA. 2005 Oct 26;294(16):2086-90.
5.Epstein D. “US sprinter Tyson Gay linked to anti-aging specialist,” SI.com; 16 July 2013.
6.Paragraph excerpted from White Paper “Guidance for Physicians on Hormone Replacement Therapy”; A4M, May 2007; available at: http://www.worldhealth.net/white-papers-official-statements/
7.Interview with Robert Goldman, M.D., Ph.D., D.O., FAASP, 27 July 2013.
8.Statement of Louis Underwood, M.D., "Abuse of Steroids in Amateur and Professional Athletics," Hearing Before the Subcommittee on Crime/ House Committee on the Judiciary, March 22, 1990).
9.Interview with Rick Collins, JD, CSCS, www.steroidlaw.com, September 2013.
10.Mitchell, S.; HGH illegal as anti-aging treatment: United Press International (UPI), Oct. 25, 2005.
11.Mollica M. “Testosterone Replacement Therapy – Why Is It So Controversial?”; http://www.brinkzone.com/bodybuilding/testosterone-replacement-therapy-why-is-it-so-controversial/; July 20, 2012.
12.Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
13.Gotherstrom G., et.al. "A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices" Journal of Clinical Endocrinology and Metabolism, 86 (10): 4657-65, Oct. 2001.
14.Gibney J, et. al., "The Effects of 10 Years of Recombinant Human Growth Hormone, (GH) in Adult GH-Deficient Patients", The Journal of Clinical Endocrinology and Metabolism, Volume 84, Number 8, August 1999.
15.Cappola AR et al. Association of IGF-I levels with muscle strength and mobility in older
